Overview
Balance Sheet
Cash Flow
Growth Analysis
2024
2023
2022
2020
2019
Profitability Metrics
Gross Margin
100.00%
Operating Margin
87.19%
Net Margin
48.27%
Efficiency Metrics
Revenue per Expense Ratio
7.81
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
0.00%
Income Tax Rate
0.00%
EPS
0.4000000000
Balance Sheet Analysis
Current Ratio
0.03
Cash Ratio
0.08
Working Capital
$-663.50M
Debt to Equity
0.57
Debt to Assets
35.99%
Equity Ratio
63.37%
Cash Flow Analysis
Operating Cash Flow Ratio
6.46%
Free Cash Flow Ratio
6.46%
CapEx to Revenue
0.00%
Dividends Paid
$44.93M
Stock Buybacks
$12.96M
Total Shareholder Returns
$57.88M
Cash Position Change
-81.73%
Key Takeaways (2024 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
365.07%
Net Income
227.34%
EPS
229.03%
Operating Income
330.01%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
1,105.04%
Operating Cash Flow
-98.44%
Free Cash Flow
-98.44%
Balance Sheet Health
Assets
1.34%
Debt
7.54%
Book Value per Share
-34.62%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
-12.19%
Shares Outstanding
-1.31%
Long Term Trends
3Y Revenue/Share
-4.14%
5Y Revenue/Share
-23.77%
3Y Dividend/Share
-25.96%
5Y Dividend/Share
-17.64%